Navigation Links
Nipro Diagnostics Leverages Managed IT Services from JDL Technologies to Support Growth and Technological Innovation
Date:4/23/2013

FORT LAUDERDALE, Fla., April 23, 2013 /PRNewswire/ -- Nipro Diagnostics, Inc., a leading producer of diabetes management solutions used around the world and trusted by premier retail pharmacies throughout the U.S., including CVS, Publix, Rite Aid and Walgreens, is driven by a mission to help the millions of people with diabetes enjoy a better quality of life.

A highly innovative manufacturer, Nipro Diagnostics has aggressive technology goals supporting their mission, and JDL Technologies is committed to enabling the company's ongoing growth and innovation by designing, deploying and managing leading-edge technology solutions to meet these goals.

For example, JDL Technologies helps to augment in-house information technology staff by managing hardware and software sourcing to ensure that the most appropriate and cost-efficient information technology solutions are successfully deployed.  The JDL TechWatch managed IT services team manage the Citrix infrastructure. When Nipro Diagnostics moved its headquarters to an 80,000-square-foot office complex it purchased in Fort Lauderdale, JDL technicians helped create the network infrastructure for the new campus.

"JDL Technologies has been an outstanding partner for almost six years, and continues to add value in enabling our growth and innovation," said Fabricio Webster , senior network manager at Nipro Diagnostics. "We rely on JDL's technological expertise to help realize our strategic vision, avoid costly pitfalls, and supplement our own dedicated IT resources. We can always count on JDL Technologies to deliver." 

Nipro Diagnostics was recently presented with the JDL Technologies Featured Client award for their continuing commitment to leveraging technology to advance their mission.  In 2011, the company was named Manufacturer of The Year by the Manufacturers Association of Florida.

Nipro Diagnostics is a wholly-owned subsidiary of Nipro Corporation, based in Osaka, Japan and a world leader in providing medical products to the healthcare community for more than 50 years. For more information, visit www.niprodiagnostics.com.       

About JDL Technologies

JDL Technologies is a managed services company specializing in designing, deploying and managing information technology solutions that enable IT organizations and small-to-medium businesses to focus on the mission-critical activities that drive their success. Our information technology solutions encompass an extensive range of networking, virtualization and cloud services. Leveraging our state-of-the-art datacenter and JDL TechWatch managed services operations center, 290 years of combined technical experience and more than 100 certifications, JDL Technologies is uniquely qualified to help organizations optimize their information technology. JDL is a wholly owned subsidiary of Communications Systems, Inc., a publicly traded company (NASDAQ-GM: JCS).  Visit us at www.jdltech.com.

Statements regarding the Company's anticipated performance in 2013 are forward-looking and involve risks and uncertainties, including but not limited to: competitive products and other factors discussed from time to time in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE JDL Technologies
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Caso Zeltiq - CLINIPRO: tribunal dá provimento à reclamação da Clinipro - LipoCryo
2. 2013 Cancer Diagnostics Market Analysis: Cancer Testing Industry Growing Rapidly
3. Quest Diagnostics Reports First Quarter 2013 Financial Results
4. Quest Diagnostics to Acquire Lab-Related Clinical Outreach Operations of Dignity Health in California and Nevada
5. Exosome Diagnostics Presents Data Demonstrating Clinical Applications of Exosome Technology in Brain Cancer, Prostate Cancer, and Alzheimers Disease at the International Society for Extracellular Vesicles 2013 Annual Meeting
6. Quest Diagnostics Completes Sale of HemoCue Business to Radiometer Medical ApS
7. Recreational Marijuana Users More Likely To Misuse Prescription Drugs, According to National Study by Quest Diagnostics
8. Penn Medicines New Center For Personalized Diagnostics Unlocks Cancers Secrets
9. Quest Diagnostics To Release First Quarter 2013 Financial Results On April 17
10. Prescription Drug Misuse Remains at Alarming Levels, According to National Study by Quest Diagnostics
11. Quest Diagnostics Names Sukumar Nagendran, M.D., Vice President, Medical Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Pulmatrix, Inc . (NASDAQ: PULM), a clinical stage biopharmaceutical company ... announced that it has added two experts in the fields ... Scientific Advisory Board . The two experts ... MD, former chief of the Pediatric Pulmonary and Allergy Divisions ... University, and David Denning , MD, ...
(Date:3/27/2017)... 27, 2017 On Friday, benchmark ... Composite closed the trading session up 0.19%; the Dow ... 500 was down 0.08%. US markets made broad based ... day in green. Pre-market today, Stock-Callers.com reviews these four ... (NASDAQ: WMGI), Amedica Corporation (NASDAQ: AMDA), MiMedx Group Inc. ...
(Date:3/27/2017)... March 27, 2017  Impax Laboratories, Inc. (NASDAQ: IPXL)today ... Paul M. Bisaro as Impax,s President and Chief ... effective March 27, 2017. Mr. Bisaro will succeed ... President and Chief Executive Officer since December of 2016. ... branded pharmaceutical experience, Mr. Bisaro, 56, is an accomplished ...
Breaking Medicine Technology:
(Date:3/27/2017)... Farmingdale, NY (PRWEB) , ... March 27, 2017 ... ... specializing in epigenetic research products enables researchers to pursue the recent RNA methylation ... RNA methylation . In light of the newfound characteristics of N6-methyladenosine, or ...
(Date:3/27/2017)... ... March 27, 2017 , ... The Association of Healthcare ... will hold their first Northeast Regional AHVAP Meeting. For 2017, Dr. Hayes will ... chain and value analysis professionals have a ‘seat at the table’ with clinical ...
(Date:3/27/2017)... ... ... According to the American Cancer Society , the average 15-year survival ... the cancer spreads to other organs, bones, or lymph nodes, however, the 5-year survival ... latter group, tune in to Lifestyle Magazine on April 9, 2017, to ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... Conventional sodium testing methods are complicated and require expert user knowledge. In a ... analytical method dedicated to the simplified, yet highly accurate, determination of sodium. , ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... agreement to resolve the pending litigation between itself and 1800 Vending DBA Healthy ... Utah). , “I am thrilled to announce that we have now reached a ...
Breaking Medicine News(10 mins):